Results 91 to 100 of about 124 (100)

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

New England Journal of Medicine, 2016
Bernard Zinman, Kirstine Brown-Frandsen, Johannes Mann   +2 more
exaly  

Gestational diabetes mellitus

Nature Reviews Disease Primers, 2019
Peter Damm, Gernot Desoye, Cuilin Zhang   +2 more
exaly  

Engineering immunomodulatory biomaterials for type 1 diabetes

Nature Reviews Materials, 2019
Benjamin Keselowsky, Ying Li, Cherie Stäbler   +2 more
exaly  

Targeting hepatic glucose metabolism in the treatment of type 2 diabetes

Nature Reviews Drug Discovery, 2016
Père Puigserver, Kfir Sharabi, Puigserver Père   +2 more
exaly  

New insights into pancreatic cancer-induced paraneoplastic diabetes

Nature Reviews Gastroenterology and Hepatology, 2013
Suresh Chari, Debabrata Mukhopadhyay, Sajan Jiv Singh Nagpal   +2 more
exaly  

Managing diabetes with nanomedicine: challenges and opportunities

Nature Reviews Drug Discovery, 2014
Daniel Griffith Anderson, Kathryn A Whitehead, Benjamin C Tang   +2 more
exaly  

ANDROGEN DEPRIVATION RAISES RISK OF DIABETES, HEART DISEASE

Ca-A Cancer Journal for Clinicians, 2007
exaly  

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

New England Journal of Medicine, 2015
Christoph Wanner, John Lachin, Bernard Zinman   +2 more
exaly  

Targeting inflammation in the treatment of type 2 diabetes: time to start

Nature Reviews Drug Discovery, 2014
Marc Donath, Donath Marc Y
exaly  

Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012

JAMA - Journal of the American Medical Association, 2015
Catherine Cowie, Linda Geiss, Sarah S Casagrande   +2 more
exaly